0
0
Industry
Geography
Report Type
Price
Publication date
Published Date
  • Product Insights

    $100 | November 2023
    Product Insights

    Buire-le-sec – Innovent

    Buire-le-sec - Innovent is an Onshore Wind project located in Hauts-de-France, France. The project is owned and developed by InnoVent. The project came online in 2017. Empower your strategies with our Buire-le-sec - Innovent report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Male Sexual Dysfunction – Drugs In Development, 2023

    Global Markets Direct’s, ‘Male Sexual Dysfunction - Drugs In Development, 2023’, provides an overview of the Male Sexual Dysfunction pipeline landscape. The report provides comprehensive information on the therapeutics under development for Male Sexual Dysfunction, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Encephalitis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Encephalitis - Drugs In Development, 2023’, provides an overview of the Encephalitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Encephalitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Hypersecretory Conditions – Drugs In Development, 2023

    Global Markets Direct’s, ‘Hypersecretory Conditions - Drugs In Development, 2023’, provides an overview of the Hypersecretory Conditions pipeline landscape. The report provides comprehensive information on the therapeutics under development for Hypersecretory Conditions, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Insulin Resistance – Drugs In Development, 2023

    Global Markets Direct’s, ‘Insulin Resistance - Drugs In Development, 2023’, provides an overview of the Insulin Resistance pipeline landscape. The report provides comprehensive information on the therapeutics under development for Insulin Resistance, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Methylmalonic Acidemia – Drugs In Development, 2023

    Global Markets Direct’s, ‘Methylmalonic Acidemia - Drugs In Development, 2023’, provides an overview of the Methylmalonic Acidemia pipeline landscape. The report provides comprehensive information on the therapeutics under development for Methylmalonic Acidemia, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Myocarditis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Myocarditis - Drugs In Development, 2023’, provides an overview of the Myocarditis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Myocarditis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Osteonecrosis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Osteonecrosis - Drugs In Development, 2023’, provides an overview of the Osteonecrosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Osteonecrosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Pouchitis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Pouchitis - Drugs In Development, 2023’, provides an overview of the Pouchitis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pouchitis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an overview of key...

  • Product Insights

    $2,000 | January 2024
    Product Insights

    Pulmonary Sarcoidosis – Drugs In Development, 2023

    Global Markets Direct’s, ‘Pulmonary Sarcoidosis - Drugs In Development, 2023’, provides an overview of the Pulmonary Sarcoidosis pipeline landscape. The report provides comprehensive information on the therapeutics under development for Pulmonary Sarcoidosis, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and latest news and press releases. Additionally, the report provides an...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.